Loading...

More Singaporean patients benefiting from personalised medicine

Image

15-Aug-17 Singapore healthcare bioanalytics firm Invitrocue and A*Star's Genome Institute have opened a joint laboratory to conduct research on personalised medicine for cancer treatment. So far, 300 patients have used the service, which costs from SGD50-200 (USD37-147). [image: Singapore General Hospital]

Read More

Chinese precision health start-up raises USD20 mn

Image

09-Aug-17 New Horizon Health, a Chinese precision health start-up focused on developing early-stage cancer screening technologies, has raised USD20 mn in a funding round from companies such as Qiming Venture, Legend Capital, SoftBank China and others. [image: China Money Network]

Read More

Konica Minolta to buy US cancer-testing company

Image

03-Jul-17 Japan's Konica Minolta plans to acquire Ambry Genetics of the US, which uses genetic data to screen for cancer, in an acquisition expected to cost JPY100 bn (USD889 mn), the office equipment maker's most expensive acquisition ever. [image: Konica Minolta]

Read More
Share